PPAR-GAMMA AGONIST ROSIGLITAZONE ALLEVIATES THE FIBROTIC PHENOTYPE OF SKIN SCLERODERMA FIBROBLASTS
Mohit Kapoor(Chitkara University), A Leask, Shiwen Xu(Northeast Agricultural University), CP Denton(The Royal Free Hospital), DJ Abraham(The Royal Free Hospital)
UCL Discovery (University College London)
July 1, 2009
Cited by 0
Related Papers
Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach
|Annals of the Rheumatic Diseases|2003|769
Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
|Annals of the Rheumatic Diseases|2010|503
Endothelin-1 Induces Expression of Matrix-associated Genes in Lung Fibroblasts through MEK/ERK
|Journal of Biological Chemistry|2004|170
The antagonistic effect of selenium on lead-induced apoptosis via mitochondrial dynamics pathway in the chicken kidney
|Chemosphere|2017|159
CCN2 Is Necessary for Adhesive Responses to Transforming Growth Factor-β1 in Embryonic Fibroblasts
|Journal of Biological Chemistry|2006|149